KYMERA THERAPEUTICS INC's ticker is KYMR and the CUSIP is 501575104. A total of 130 filers reported holding KYMERA THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.03 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $263,572 | -37.3% | 18,962 | +3.7% | 0.00% | -33.3% |
| Q2 2023 | $420,441 | -22.2% | 18,288 | +0.2% | 0.00% | -25.0% |
| Q1 2023 | $540,718 | +21.1% | 18,249 | +2.0% | 0.00% | +33.3% |
| Q4 2022 | $446,435 | +14.2% | 17,886 | -0.4% | 0.00% | 0.0% |
| Q3 2022 | $391,000 | +12.4% | 17,951 | +1.4% | 0.00% | +50.0% |
| Q2 2022 | $348,000 | -51.8% | 17,698 | +3.7% | 0.00% | -50.0% |
| Q1 2022 | $722,000 | -37.7% | 17,060 | -6.6% | 0.00% | -33.3% |
| Q4 2021 | $1,159,000 | +4.9% | 18,261 | -2.9% | 0.01% | 0.0% |
| Q3 2021 | $1,105,000 | +40.6% | 18,807 | +16.1% | 0.01% | +100.0% |
| Q2 2021 | $786,000 | +244.7% | 16,198 | +175.6% | 0.00% | +200.0% |
| Q1 2021 | $228,000 | -37.2% | 5,877 | +0.3% | 0.00% | 0.0% |
| Q4 2020 | $363,000 | – | 5,861 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AJU IB Investment Co., Ltd. | 457,059 | $9,950,000 | 17.03% |
| Atlas Venture Life Science Advisors, LLC | 6,875,698 | $149,684,000 | 16.52% |
| BVF INC/IL | 4,692,604 | $102,158,000 | 4.22% |
| Aquilo Capital Management, LLC | 330,246 | $7,189,000 | 2.59% |
| Redmile Group, LLC | 2,876,637 | $62,624,000 | 2.43% |
| Artal Group S.A. | 1,500,000 | $32,655,000 | 1.39% |
| Deer Management Co. LLC | 615,895 | $13,408,000 | 0.94% |
| Avoro Capital Advisors LLC | 2,169,230 | $47,224,000 | 0.87% |
| AtonRa Partners | 34,462 | $750,000 | 0.74% |
| Rock Springs Capital Management LP | 1,046,743 | $22,788,000 | 0.59% |